Case Studies

Oncology adherence program


Clinical trials showed a 50% discontinuation of treatment within the first 8 weeks of therapy. This was due to several challenges: difficulty staying adherent to 2x daily oral oncolytic, older age of the patient population, and side effects.


Develop a patient community to seamlessly onboard patients to their oral oncolytic, provide educational content and insights to address their questions, and connect them with peers & community managers to leave ‘no patient alone’

  • - AI matched patients for peer mentorship
  • - Proactively educate on side effects
  • - Push notifications for medication adherence & tracking
  • - PSP connectivity cross-validated patient status
  • - PSP ID used as gating mechanism
A phone screen showing Oncology user app


  • 86% of patients in app monthly
  • 71% of patients stayed on therapy past 8-week checkpoint
  • 73% of patients said the app helped them better manage and report side effects
  • 70% of patients digested 4 educational health programs
We’re here to help you easily deliver best in class therapy management and patient support.